アジア太平洋のゲノムがんパネルとプロファイリング市場：用途別、エンドユーザー別、国別：分析と予測（2023年～2033年）

アジア太平洋のゲノムがんパネルとプロファイリングの市場規模は、2023年の15億6,000万米ドルから2033年には47億8,000万米ドルに達すると予測されています。

この成長の原動力は、ゲノム研究の進展と、がん領域における精密医療への注目の高まりです。

アジア太平洋のゲノムがんパネルとプロファイリング市場は、がんの罹患率の上昇と地域全体での個別化医療の採用の増加に後押しされ、大きな成長を遂げています。ゲノム技術の進歩と次世代シーケンシング（NGS）の機能拡大により、がん診断と治療戦略の精度が向上し、個人の遺伝子プロファイルに特化した治療が可能になっています。政府やヘルスケア機関は、ヘルスケアインフラやゲノム研究への投資を増やしており、市場の拡大をさらに促進しています。さらに、バイオテクノロジー企業間の共同研究が、先進的なゲノム検査へのアクセスを後押ししています。この市場の成長は、がんの早期発見や標的治療の利点に対する一般市民の意識の高まりにも支えられており、アジア太平洋地域はがんゲノム医療の展望において重要な地域となっています。

当レポートでは、アジア太平洋のゲノムがんパネルとプロファイリング市場について調査し、市場の概要とともに、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 製品定義
• 包含基準と除外基準
• 市場範囲
• 調査手法
• 市場概要

第2章 地域別

• 概要
• アジア太平洋

第3章 企業プロファイル

• Burning Rock DX
• Genecast Biotechnology Co., Ltd

List of Figures

• Figure 1: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 2: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
• Figure 3: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
• Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
• Figure 5: Genomic Cancer Panel and Profiling Market Segmentation
• Figure 6: Genomic Cancer Panel and Profiling Market: Research Methodology
• Figure 7: Primary Research Methodology
• Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 9: Top-Down Approach (Segment-Wise Analysis)
• Figure 10: Genomic Cancer Panel and Profiling Workflow, End User Perspective
• Figure 11: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
• Figure 12: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 13: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
• Figure 14: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
• Figure 15: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
• Figure 16: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
• Figure 17: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
• Figure 18: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 19: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 20: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 21: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 22: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 23: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
• Figure 24: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
• Figure 25: Burning Rock DX: Product Portfolio
• Figure 26: Genecast Biotechnology Co., Ltd: Product Portfolio

List of Tables

• Table 1: Technological Trends in the Genomic Cancer Panel and Profiling Market
• Table 2: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis

Introduction to Asia-Pacific Genomic Cancer Panel and Profiling Market

The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology.

Market Introduction

The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.

Market Segmentation

Segmentation 1: by Application

• Clinical
• Research

Segmentation 2: by End User

• Hospitals
• Clinical and Diagnostic Laboratories
• Research and Academic Institutes
• Other End Users

Segmentation 3: by Country

• China
• Japan
• India
• Australia
• South Korea
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

• Burning Rock DX
• Genecast Biotechnology Co., Ltd

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
  • 1.2.1 Inclusion Criteria
  • 1.2.2 Exclusion Criteria
• 1.3 Market Scope
  • 1.3.1 Scope of the Study
  • 1.3.2 Key Questions Answered in this Report
• 1.4 Research Methodology
  • 1.4.1 Genomic Cancer Panel and Profiling Market: Research Methodology
  • 1.4.2 Data Sources
  • 1.4.3 Market Estimation Model
  • 1.4.4 Criteria for Company Profiling
• 1.5 Market Overview
  • 1.5.1 Market Definition
  • 1.5.2 Market Footprint and Growth Potential
  • 1.5.3 Future Potential

2 By Region

• 2.1 Overview
• 2.2 Asia-Pacific
  • 2.2.1 Key Dynamics
  • 2.2.2 China
  • 2.2.3 Japan
  • 2.2.4 India
  • 2.2.5 Australia
  • 2.2.6 South Korea
  • 2.2.7 Rest-of-Asia-Pacific

3 Company Profiles

• 3.1 Overview
• 3.2 Burning Rock DX
  • 3.2.1 Company Overview
  • 3.2.2 Role of Burning Rock DX in the Genomic Cancer Panel and Profiling Market
  • 3.2.3 Business Strategies
  • 3.2.4 Analyst Perspective
• 3.3 Genecast Biotechnology Co., Ltd
  • 3.3.1 Company Overview
  • 3.3.2 Role of Genecast Biotechnology Co., Ltd in the Genomic Cancer Panel and Profiling Market
  • 3.3.3 Analyst Perspective